Impaired glucose tolerance in patients with chronic hypoxic pulmonary disease

Diabetes and Metabolism

Volumn 22, Issue 1, 1996, Pages 37-42

  Hjalmarsen, A ^a,b   Aasebo U ^a   Birkeland, K ^a   Sager, G ^b   Jorde, R ^c  

^a AKER UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^c Department of Pulmonary Medicine

Author keywords

adrenaline; cortisol; glucagon; glucose; growth hormone; insulin; oxygen therapy

Indexed keywords

ADRENALIN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; DIGITOXIN; FUROSEMIDE; GLUCAGON; GLUCOSE; GROWTH HORMONE; HYDROCORTISONE; INSULIN; IPRATROPIUM BROMIDE; PREDNISOLONE; STEROID; THEOPHYLLINE; OXYGEN;

ADULT; ANKLE EDEMA; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HORMONE BLOOD LEVEL; HORMONE RESPONSE; HUMAN; HYPOXEMIA; IMPAIRED GLUCOSE TOLERANCE; INHALATIONAL DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; ORAL GLUCOSE TOLERANCE TEST; OXYGEN THERAPY; AGED; ANOXIA; BLOOD; GLUCOSE INTOLERANCE; LUNG DISEASE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; GLUCOSE TOLERANCE; HYPOXIA;

AGED; ANOXIA; BLOOD GLUCOSE; FEMALE; GLUCOSE INTOLERANCE; HUMANS; INSULIN; LUNG DISEASES; MALE; MIDDLE AGED; OXYGEN;

EID: 0029665733     PISSN: 03381684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Semple PDA, Beastall GH, Watson WS, Hume R. Hypothalamicpituitary dysfunction in respiratory hypoxia. Thorax, 1981, 36, 605-9.
2. Medical Research Council Working Party. Long-term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphasema. Lancet, 1981, 8222, 681-86.
3. Baudouin SV, Bott I, Ward A, Deane C, Moxham J. Short-term effect on renal haemodynamics in patients with hypoxaemic chronic obstructive airways disease. Thorax, 1992, 47, 550-54.
4. Aasebø U, Gyltnes A, Bremnes RM, Aakvaag A. Reversal of sexual impotence in male patients with chronic obstructive pulmonary disease and hypoxemia with long-term oxygen therapy. J Steroid Biochem Molec Biol, 1993, 46, 799-803.
5. Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxic chronic obstructive lung disease. Annals of Inrernal Medicine, 1980, 93, 391-98.
6. Baiter MS, Daniak N, Chapman KR, Sorba SA, Rebuck AS. Erythropoietin response to acute hypoxemia in patients with chronic pulmonary disease. Chest, 1992, 102, 482-85.
7. Grant I, Heaton RK, McSweeny AJ, Adams KM, Timms RM. Neuropsychologic findings in hypoxemic chronic obstructive pulmonary disease. Arch Int Med, 1982, 142, 1470-76.
8. World Health Organisation. Handbook for reporting results of cancer treatment. WHO offset publication No. 48, Geneva : WHO, 1979.
9. 1-blockade on glucose thresholds for release of counterregulatory hormones and symptoms in insulin-dependent diabetes mellitus. Acta Endocrinol, 1992, 126, 264-70.
10. Cederholm J, Wibell L. Evaluation of insulin release and relative peripheral resistance with use of the oral glucose tolerance test : a study in subjects with normoglycaemia, glucose intolerance and non-insulin-dependent diabetes mellitus. Scand J Clin Lab Invest, 1985, 45, 741-51.
11. Lillioja S, Mott DM, Howard BV et al. Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. N Engl J Med, 1988, 318, 1217-25.
12. McMahon M, Gerich J, Rizza R. Effects of glucocorticoids on carbohydrate metabolism. Diabetes/Metabolism Reviews, 1988, 4(1), 17-30.
13. Owen OE, Cahill GF. Metabolic effects of exogenous glucocorticoids in fasted man. J Clin Invest, 1973, 52, 2596-2605.
14. Cavallo-Perin P, Bruno A, Ozzello A et al. Comparison of acute and subacute effects of deflazacort and prednisone on glucose metabolism in man. Eur J Clin Pharmacol, 1984, 26, 357-62.
15. Foley MR, Landon MB, Gabbe SG et al. Effect of prolonged oral terbutaline therapy on glucose tolerance in pregnancy. Am J Obstet Gyneco, 1993, 168(1), 100-5.
16. Boe J, Bakke P, Rødølen T, Skovlund E, Gulsvik A. High-dose inhaled steroids in asthmatics : moderate efficacy gain and suppression of the hypothalamic-pituitary-adrenal (HPA) axis. Eur Respir J, 1994, 7, 2179-84.
17. Løfdahl C-G, Mellstrand T, Svedmyr N. Glucocorticoids and asthma. Studies of resistance and systemic effects of glucocorticoids. Europ J Respir Dis Suppl, 1984, 136(65), 69-77.
18. Perron L, Mitchell D, Tremblay A, Despres J-P, Nadeau A, Bouchard C. The role of body fat in insulin sensitivity of endurance athletes. Diabete & Metabolisme, 1986, 12, 233-38.
19. Vea H, Jorde R, Sager G, Vaaler S, Sundsfjord J. Reproducibility of glycaemic thresholds for activation of counterregulatory hormones and hypoglycaemic symptoms in healthy subjects. Diabetologia, 1992, 35, 958-61.
20. Salter CP, Fluck DC, Stimmler L. Effect of open-heart surgery on growth-hormone levels in man. Lancet, 1972, ii, 853.
21. Schols AMWJ, Soeters PB, Dingemans AMC, Mostert B, Frantzen PJ, Wouters EFM. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis, 1993, 147, 1151-56.
22. Rofe AM, Bourgeois CS, Coyle P, Taylor A, Abdi EA. Altered insulin response to glucose in weightlosing cancer patients. Anticancer-Res, 1994, 14(2B), 647-50.